SmartGene

What SmartGene does

SmartGene AG is a Switzerland- or Germany-domiciled bioinformatics software company that builds the IDNS (Integrated Database Network System), a platform for automated gene sequence interpretation used in clinical diagnostics, medical research, public health, biopharmaceutical quality control, and food integrity applications. The platform is delivered through a portfolio of specialized application modules covering bacterial and fungal identification, microbiome analysis (16S), HIV, HCV, Influenza, Coronaviruses, HSV-1&2, CMV, molecular typing, and NGS workflows, all anchored on a proprietary centroid-based analysis methodology against curated, regularly refreshed reference databases. Complementing the core platform, IDNS Networks enables data sharing and collaboration across distributed laboratories, and the company offers expert consulting services for sequence analysis and molecular diagnostics implementation.

The company runs a sales-led, account-based go-to-market: customers request access to a gated Customer Area, and SmartGene maintains separate direct contact channels for Europe and North America, with quote-based, non-publicly-disclosed pricing that is consistent with enterprise SaaS subscription or per-application licensing. The technology stack is computational-biology-native rather than AI-native; for example, the HIV application integrates Stanford's HIVDB (updated to version 10.1 in January 2026) for genotypic drug resistance interpretation, and the centroid-based analysis has been cited as a validation method in a peer-reviewed publication from Versailles Central Hospital, France. Recent product activity in 2025-2026 includes new HSV-1&2 and CMV application launches, a fungal reference database refresh, and the HIVDB 10.1 implementation, indicating an active development cadence.

Name

SmartGene

Legal name

SmartGene AG

Website

https://smartgene.ch

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

SmartGene AG provides the IDNS gene sequence interpretation platform and a suite of specialized pathogen and microbiome application modules, serving clinical diagnostics, medical research, public health, biopharmaceutical, and food integrity customers in Europe and North America.

Ownership category

akta.pro rank

Product category

Bioinformatics Software

NAICS

Software Publishers (5132), Software Publishers (513210)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Laboratory-Based Surveillance & Genomic Epidemiology (WGS/NGS) (HLAJABAC), Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)

Keywords

• Genomic data analysis
• Gene sequence interpretation
• Clinical diagnostics software
• Molecular epidemiology platforms
• Bioinformatics consulting services

Headquarters

HQ city

Lausanne

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Subscription-based Software Services: SmartGene provides access to its IDNS platform through customer accounts, suggesting a subscription-based model. The platform offers various Apps for specific applications (Bacteria, Fungi, Microbiomes, HIV, HCV, Influenza, Coronaviruses, Typing, NGS Apps) indicating modular subscription tiers or per-application licensing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

SmartGene provides an automated gene sequence interpretation and identification platform (IDNS - Integrated Database Network System) for clinical diagnostics, medical research, public health, biopharma, and food integrity applications. The platform combines centroid-based analysis methodology with regularly updated specialized reference databases for Bacteria, Fungi, and viruses (HIV, HCV, Influenza, Coronaviruses, HSV-1&2, CMV). Customers access the platform through account-based subscriptions and a portfolio of application modules supporting both next-generation and dideoxynucleotide sequencing methods.

Product overview

SmartGene offers a unified platform architecture centered on its proprietary IDNS (Integrated Database Network System) technology, which provides gene sequence interpretation across multiple disease areas. The platform operates through a portfolio of specialized application modules including Bacteria, Bacteria for SeqStudio™, Fungi, Microbiomes (16S), HIV, HCV, Influenza, Coronaviruses, HSV-1&2, CMV, Typing, and NGS Apps. These applications share the core IDNS technology for centroid-based sequence analysis and database matching, while IDNS Networks enables collaborative data sharing across institutions. The company also provides professional consulting services. Markets served include Clinical Diagnostics (precision medicine), Medical Research, Public Health (molecular epidemiology), BioPharma (product quality), and Food Integrity.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Centroid-based analysis validated as effective method for Bacteria 16S sequencing identification in peer-reviewed publication from Versailles Central Hospital, France

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature1 record

Recent moves5 records

Expansion highlights5 records

Emerging players

• Benchling: Benchling is a cloud-based R&D platform that increasingly incorporates sequence analysis and lab informatics for biotech customers, competing for the BioPharma and Medical Research wallet that SmartGene also targets.
• CosmosID: CosmosID offers microbiome and pathogen identification services using proprietary genomic databases and cloud-based analysis, partially overlapping with SmartGene's 16S Microbiome and Bacteria apps.

Direct peers

• DNASTAR: DNASTAR provides Lasergene, a long-standing sequence analysis software suite, competing with SmartGene in gene sequence interpretation, alignment, and assembly for clinical and research users.
• Geneious (Biomatters): Geneious is a widely used molecular biology software suite for DNA/RNA sequence analysis, offering comparable desktop and cloud-based tools to SmartGene's IDNS for alignment, variant calling, and phylogenetic analysis.
• Qiagen (CLC bio / Digital Insights): Qiagen's CLC bio and Digital Insights offer leading bioinformatics platforms for sequence analysis, directly competing with SmartGene's IDNS across NGS, microbial typing, and clinical genomics workflows.
• BioNumerics (Applied Maths): BioNumerics is a dedicated platform for microbial typing, genomic surveillance, and epidemiology. It directly overlaps with SmartGene's Typing and IDNS Networks modules used in public health and molecular epidemiology.

Broad incumbents

• Illumina (DRAGEN / BaseSpace): Illumina bundles DRAGEN secondary analysis and BaseSpace with its sequencing platforms, providing comparable bioinformatics capability as part of a broader sequencing ecosystem that dwarfs SmartGene's standalone offerings.
• Thermo Fisher Scientific (SeqStudio / Ion Torrent software): Thermo Fisher offers instrument-aligned analysis software for its SeqStudio and Ion Torrent platforms. SmartGene already integrates with SeqStudio, positioning Thermo Fisher as both a partner and a broad incumbent that could expand its own software stack.
• bioMérieux (bioinformatics / molecular diagnostics): bioMérieux provides molecular diagnostics and bioinformatics for clinical microbiology. Its broader diagnostics portfolio and reference database assets overlap with SmartGene's clinical diagnostics and food integrity applications.

Others

• Stanford HIVDB (Stanford University): Stanford HIVDB is the authoritative HIV genotypic resistance algorithm that SmartGene embeds. It is an ecosystem participant and algorithm provider rather than a competitor, but it shapes the standard SmartGene aligns to.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SmartGene